Flow chart of study population. IgAN ... In the present study of 93 patients with IgAN, we found that treatment with SGLT2 inhibitors (SGLT2i) for three and six months led to a notable reduction in ...
SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...
sodium-glucose transporter 2 (SGLT2) inhibitors — these reduce the amount of glucose reabsorbed by the kidneys, meaning that it is excreted in the urine. A meta-analysis, published in the ...
New York, USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight The FDA’s recent approval of OZEMPIC ...
Fourth-Quarter Adjusted EPS: $2.24. Free Cash Flow: $281 million in Q4 and $1.16 billion for the full year. US Treatment Volume Growth: 30 basis points increase in Q4 over the previous year.
Lola Young’s breakthrough hit Messy transcends its TikTok virality to finally take the top spot on this week’s Official Singles Chart. Displacing Gracie Abrams’ That’s So True after a ...
You can find her on X @billiemelissa_. Languages: English. Gints Zilbalodis' wordless film Flow, which follows Cat, a solitary animal whose home is devastated by a great flood, is now available to ...
The original soundtrack to his acclaimed Michael Gracey-directed biopic, Better Man outsells the rest of the Top 5 combined to stand proud at the summit of the Official Albums Chart; now drawing ...
Taylor Swift has made charts history, becoming the female artist with the most albums to have reached number one in the UK. Lover (Live From Paris) netted Swift her 13th number one album on the UK ...
Eric Clapton’s fifth solo album Slowhand debuts on Billboard's Top Blues Albums chart at No. 2, ... [+] nearly netting the guitarist another No. 1. British guitarist Eric Clapton performing on ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...